MicroRNAs: Emerging players in the pathogenesis of vitiligo
Vitiligo is an autoimmune skin disease characterized by presence of pale patchy areas of depigmentation. MicroRNAs (miRNAs) are important regulators of gene expression and play significant roles in diverse biological and pathological processes. Accumulating evidence has shown that miRNAs were differ...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2022.964982/full |
_version_ | 1818023038176722944 |
---|---|
author | Xin Yu Yuli Cui Xueqing Zhu Hongjun Xu Linfeng Li Guangcheng Gao |
author_facet | Xin Yu Yuli Cui Xueqing Zhu Hongjun Xu Linfeng Li Guangcheng Gao |
author_sort | Xin Yu |
collection | DOAJ |
description | Vitiligo is an autoimmune skin disease characterized by presence of pale patchy areas of depigmentation. MicroRNAs (miRNAs) are important regulators of gene expression and play significant roles in diverse biological and pathological processes. Accumulating evidence has shown that miRNAs were differentially expressed in skin lesions and peripheral blood mononuclear cells of patients with vitiligo. In particular, miRNAs are significantly correlated with the development and progression of vitiligo. The abundance of some miRNAs in serum was also correlated with the vitiligo lesion severity, indicating that miRNAs might serve as prognostic biomarkers. Importantly, the direct involvement of miRNAs in the pathogenesis of vitiligo has been demonstrated. For example, increased expression of miR-25 contributes to vitiligo through promoting the dysfunction and oxidative stress-induced destruction of melanocytes. However, there are limited studies on the function and mechanism of deregulated miRNAs in vitiligo. Further studies are required to establish clinical applications of miRNAs for vitiligo. More in-depth investigations of miRNAs are needed for the understanding of the pathogenesis of vitiligo and the development of novel therapeutic targets. This present review summarizes the current literature on the deregulation and pathogenic roles of miRNAs in vitiligo. We also highlight the potential clinical applications of miRNAs in patients with vitiligo. |
first_indexed | 2024-12-10T03:37:58Z |
format | Article |
id | doaj.art-e3d88e02653f4c9bb0af42977bee01ca |
institution | Directory Open Access Journal |
issn | 2296-634X |
language | English |
last_indexed | 2024-12-10T03:37:58Z |
publishDate | 2022-09-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Cell and Developmental Biology |
spelling | doaj.art-e3d88e02653f4c9bb0af42977bee01ca2022-12-22T02:03:40ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2022-09-011010.3389/fcell.2022.964982964982MicroRNAs: Emerging players in the pathogenesis of vitiligoXin YuYuli CuiXueqing ZhuHongjun XuLinfeng LiGuangcheng GaoVitiligo is an autoimmune skin disease characterized by presence of pale patchy areas of depigmentation. MicroRNAs (miRNAs) are important regulators of gene expression and play significant roles in diverse biological and pathological processes. Accumulating evidence has shown that miRNAs were differentially expressed in skin lesions and peripheral blood mononuclear cells of patients with vitiligo. In particular, miRNAs are significantly correlated with the development and progression of vitiligo. The abundance of some miRNAs in serum was also correlated with the vitiligo lesion severity, indicating that miRNAs might serve as prognostic biomarkers. Importantly, the direct involvement of miRNAs in the pathogenesis of vitiligo has been demonstrated. For example, increased expression of miR-25 contributes to vitiligo through promoting the dysfunction and oxidative stress-induced destruction of melanocytes. However, there are limited studies on the function and mechanism of deregulated miRNAs in vitiligo. Further studies are required to establish clinical applications of miRNAs for vitiligo. More in-depth investigations of miRNAs are needed for the understanding of the pathogenesis of vitiligo and the development of novel therapeutic targets. This present review summarizes the current literature on the deregulation and pathogenic roles of miRNAs in vitiligo. We also highlight the potential clinical applications of miRNAs in patients with vitiligo.https://www.frontiersin.org/articles/10.3389/fcell.2022.964982/fullMicroRNAsvitiligopathogenesismiRNAMiR-25 |
spellingShingle | Xin Yu Yuli Cui Xueqing Zhu Hongjun Xu Linfeng Li Guangcheng Gao MicroRNAs: Emerging players in the pathogenesis of vitiligo Frontiers in Cell and Developmental Biology MicroRNAs vitiligo pathogenesis miRNA MiR-25 |
title | MicroRNAs: Emerging players in the pathogenesis of vitiligo |
title_full | MicroRNAs: Emerging players in the pathogenesis of vitiligo |
title_fullStr | MicroRNAs: Emerging players in the pathogenesis of vitiligo |
title_full_unstemmed | MicroRNAs: Emerging players in the pathogenesis of vitiligo |
title_short | MicroRNAs: Emerging players in the pathogenesis of vitiligo |
title_sort | micrornas emerging players in the pathogenesis of vitiligo |
topic | MicroRNAs vitiligo pathogenesis miRNA MiR-25 |
url | https://www.frontiersin.org/articles/10.3389/fcell.2022.964982/full |
work_keys_str_mv | AT xinyu micrornasemergingplayersinthepathogenesisofvitiligo AT yulicui micrornasemergingplayersinthepathogenesisofvitiligo AT xueqingzhu micrornasemergingplayersinthepathogenesisofvitiligo AT hongjunxu micrornasemergingplayersinthepathogenesisofvitiligo AT linfengli micrornasemergingplayersinthepathogenesisofvitiligo AT guangchenggao micrornasemergingplayersinthepathogenesisofvitiligo |